All Stories

  1. Screening approaches for the identification of Nrf2-Keap1 protein-protein interaction inhibitors targeting hot spot residues

    Article • SLAS DISCOVERY, March 2024, Elsevier

    Rie Hantani

  2. Optimization Efforts for Identification of Novel Highly Potent Keap1-Nrf2 Protein–Protein Interaction Inhibitors

    Article • Journal of Medicinal Chemistry, February 2024, American Chemical Society (ACS)

    Rie Hantani

  3. Methyl and Fluorine Effects in Novel Orally Bioavailable Keap1–Nrf2 PPI Inhibitor

    Article • ACS Medicinal Chemistry Letters, April 2023, American Chemical Society (ACS)

    Rie Hantani

  4. SAR study of small molecule inhibitors of the programmed cell death‐1/programmed cell death‐ligand 1 interaction

    Article • Chemical Biology & Drug Design, September 2021, Wiley

    Rie Hantani

  5. Symmetry-based ligand design and evaluation of small molecule inhibitors of programmed cell death-1/programmed death-ligand 1 interaction

    Article • Bioorganic & Medicinal Chemistry Letters, September 2019, Elsevier

    Rie Hantani

  6. Identification of a New Inhibitor That Stabilizes Interleukin-2-Inducible T-Cell Kinase in Its Inactive Conformation

    Article • SLAS DISCOVERY, June 2019, SAGE Publications

    Rie Hantani

  7. Identification of Novel Phospholipid Transfer Protein Inhibitors by High-Throughput Screening

    Article • SLAS DISCOVERY, April 2019, SAGE Publications

    Rie Hantani

  8. Identification of inactive conformation-selective interleukin-2-inducible T-cell kinase (ITK) inhibitors based on second-harmonic generation

    Article • FEBS Open Bio, July 2018, Wiley

    Rie Hantani